HEADER IMMUNE SYSTEM 20-JUN-13 4LAS TITLE CRYSTAL STRUCTURE OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX TITLE 2 WITH 4-HYDROXYMETHAMPHETAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SINGLE CHAIN ANTIBODY FRAGMENT SCFV6H4; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: KM71H; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPICZ-ALPHA KEYWDS METHAMPHETAMINE, ANTI-METHAMPHETAMINE ANTIBODY, THERAPEUTIC ANTIBODY, KEYWDS 2 SCFV, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.CELICAL,K.GOKULAN,E.C.PETERSON,K.I.VARUGHESE REVDAT 3 25-DEC-19 4LAS 1 TITLE COMPND SOURCE JRNL REVDAT 3 2 1 REMARK DBREF SEQRES HELIX REVDAT 3 3 1 SHEET SSBOND SITE ATOM REVDAT 2 17-JUL-19 4LAS 1 REMARK REVDAT 1 11-DEC-13 4LAS 0 JRNL AUTH E.C.PETERSON,R.CELIKEL,K.GOKULAN,K.I.VARUGHESE JRNL TITL STRUCTURAL CHARACTERIZATION OF A THERAPEUTIC JRNL TITL 2 ANTI-METHAMPHETAMINE ANTIBODY FRAGMENT: OLIGOMERIZATION AND JRNL TITL 3 BINDING OF ACTIVE METABOLITES. JRNL REF PLOS ONE V. 8 82690 2013 JRNL REFN ESSN 1932-6203 JRNL PMID 24349338 JRNL DOI 10.1371/JOURNAL.PONE.0082690 REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 8164 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.164 REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 405 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.33 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 REFLECTION IN BIN (WORKING SET) : 574 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.1710 REMARK 3 BIN FREE R VALUE SET COUNT : 42 REMARK 3 BIN FREE R VALUE : 0.2580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1775 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 71 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.09000 REMARK 3 B22 (A**2) : -1.16000 REMARK 3 B33 (A**2) : -0.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.36000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.636 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.275 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.181 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.494 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1825 ; 0.014 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1621 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2460 ; 1.594 ; 1.954 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3742 ; 0.800 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 218 ; 7.155 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 70 ;37.393 ;23.714 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 285 ;15.748 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;20.213 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 268 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2002 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 416 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4LAS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1000080396. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8577 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.330 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : 0.03000 REMARK 200 FOR THE DATA SET : 32.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6M AMMONIUM SULFATE, 240 MM REMARK 280 IMIDAZOLE MALATE, PH 8.0., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 287.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.64850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY H 117A REMARK 465 GLY H 117B REMARK 465 GLY H 117C REMARK 465 GLY H 117D REMARK 465 SER H 117E REMARK 465 GLY H 117F REMARK 465 GLY H 117G REMARK 465 GLY H 117H REMARK 465 GLY H 117I REMARK 465 SER H 117J REMARK 465 PRO H 233 REMARK 465 HIS H 234 REMARK 465 HIS H 235 REMARK 465 HIS H 236 REMARK 465 HIS H 237 REMARK 465 HIS H 238 REMARK 465 HIS H 239 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH H 653 O HOH H 668 1.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH H 602 O HOH H 622 2545 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU H 106 CD GLU H 106 OE1 -0.070 REMARK 500 GLU H 106 CD GLU H 106 OE2 -0.083 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER H 149 O - C - N ANGL. DEV. = 10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER H 15 -12.19 71.73 REMARK 500 SER H 31 -178.23 -170.32 REMARK 500 ASN H 43 7.98 89.22 REMARK 500 THR H 174 -49.52 71.19 REMARK 500 ALA H 207 173.28 176.41 REMARK 500 ARG H 231 99.24 99.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1WF H 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GKZ RELATED DB: PDB REMARK 900 SINGLE CHAIN VARIABLE FRAGMENT REMARK 900 RELATED ID: 4LAQ RELATED DB: PDB REMARK 900 RELATED ID: 4LAR RELATED DB: PDB DBREF 4LAS H 1 239 PDB 4LAS 4LAS 1 239 SEQRES 1 H 249 GLU VAL GLN LEU GLN GLU SER GLY PRO SER LEU VAL LYS SEQRES 2 H 249 PRO SER GLN THR LEU SER LEU THR CYS SER VAL THR GLY SEQRES 3 H 249 ASP SER VAL THR SER GLY TYR TRP SER TRP ILE ARG GLN SEQRES 4 H 249 PHE PRO GLY ASN LYS LEU ASP TYR MET GLY TYR ILE SER SEQRES 5 H 249 TYR ARG GLY SER THR TYR TYR ASN PRO SER LEU LYS SER SEQRES 6 H 249 ARG ILE SER ILE THR ARG ASP THR SER LYS ASN GLN VAL SEQRES 7 H 249 TYR LEU GLN LEU LYS SER VAL SER SER GLU ASP THR ALA SEQRES 8 H 249 THR TYR TYR CYS SER TYR PHE ASP SER ASP ASP TYR ALA SEQRES 9 H 249 MET GLU TYR TRP GLY GLN GLY THR SER VAL THR VAL SER SEQRES 10 H 249 GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLY GLY GLY SEQRES 11 H 249 GLY SER GLN ILE VAL LEU THR GLN SER PRO ALA ILE MET SEQRES 12 H 249 SER ALA SER PRO GLY GLU LYS VAL THR LEU THR CYS SER SEQRES 13 H 249 ALA SER SER SER VAL SER SER SER HIS LEU TYR TRP TYR SEQRES 14 H 249 GLN GLN LYS PRO GLY SER SER PRO LYS LEU TRP ILE TYR SEQRES 15 H 249 SER THR SER ASN LEU ALA SER GLY VAL PRO ALA ARG PHE SEQRES 16 H 249 SER GLY SER GLY SER GLY THR SER TYR SER LEU THR ILE SEQRES 17 H 249 SER SER MET GLU ALA GLU ASP ALA ALA SER TYR PHE CYS SEQRES 18 H 249 HIS GLN TRP SER SER PHE PRO PHE THR PHE GLY SER GLY SEQRES 19 H 249 THR LYS LEU GLU ILE LYS ARG ALA PRO HIS HIS HIS HIS SEQRES 20 H 249 HIS HIS HET 1WF H 500 12 HETNAM 1WF 4-[(2S)-2-(METHYLAMINO)PROPYL]PHENOL HETSYN 1WF 4-HYDROXYMETHAMPHETAMINE FORMUL 2 1WF C10 H15 N O FORMUL 3 HOH *71(H2 O) HELIX 1 1 PRO H 61 SER H 65 5 5 HELIX 2 2 THR H 73 LYS H 75 5 3 HELIX 3 3 SER H 86 THR H 90 5 5 HELIX 4 4 SER H 152 SER H 154 5 3 HELIX 5 5 GLU H 202 ALA H 206 5 5 SHEET 1 A 4 VAL H 2 SER H 7 0 SHEET 2 A 4 LEU H 18 GLY H 26 -1 O THR H 25 N GLN H 3 SHEET 3 A 4 GLN H 77 LEU H 82 -1 O LEU H 82 N LEU H 18 SHEET 4 A 4 ILE H 67 ASP H 72 -1 N THR H 70 O TYR H 79 SHEET 1 B 6 LEU H 11 VAL H 12 0 SHEET 2 B 6 THR H 112 VAL H 116 1 O THR H 115 N VAL H 12 SHEET 3 B 6 ALA H 91 PHE H 98 -1 N TYR H 93 O THR H 112 SHEET 4 B 6 TYR H 33 GLN H 39 -1 N ILE H 37 O TYR H 94 SHEET 5 B 6 LEU H 45 SER H 52 -1 O ASP H 46 N ARG H 38 SHEET 6 B 6 THR H 57 TYR H 59 -1 O TYR H 58 N TYR H 50 SHEET 1 C 4 LEU H 11 VAL H 12 0 SHEET 2 C 4 THR H 112 VAL H 116 1 O THR H 115 N VAL H 12 SHEET 3 C 4 ALA H 91 PHE H 98 -1 N TYR H 93 O THR H 112 SHEET 4 C 4 TYR H 107 TRP H 108 -1 O TYR H 107 N TYR H 97 SHEET 1 D 4 LEU H 126 THR H 127 0 SHEET 2 D 4 VAL H 141 ALA H 147 -1 O SER H 146 N THR H 127 SHEET 3 D 4 SER H 193 ILE H 198 -1 O LEU H 196 N LEU H 143 SHEET 4 D 4 PHE H 185 SER H 190 -1 N SER H 188 O SER H 195 SHEET 1 E 6 ILE H 132 ALA H 135 0 SHEET 2 E 6 THR H 225 ILE H 229 1 O GLU H 228 N MET H 133 SHEET 3 E 6 ALA H 207 GLN H 213 -1 N ALA H 207 O LEU H 227 SHEET 4 E 6 LEU H 156 GLN H 161 -1 N TYR H 157 O HIS H 212 SHEET 5 E 6 LYS H 168 TYR H 172 -1 O LYS H 168 N GLN H 160 SHEET 6 E 6 ASN H 176 LEU H 177 -1 O ASN H 176 N TYR H 172 SHEET 1 F 4 ILE H 132 ALA H 135 0 SHEET 2 F 4 THR H 225 ILE H 229 1 O GLU H 228 N MET H 133 SHEET 3 F 4 ALA H 207 GLN H 213 -1 N ALA H 207 O LEU H 227 SHEET 4 F 4 THR H 220 PHE H 221 -1 O THR H 220 N GLN H 213 SSBOND 1 CYS H 22 CYS H 95 1555 1555 2.06 SSBOND 2 CYS H 145 CYS H 211 1555 1555 2.12 CISPEP 1 SER H 129 PRO H 130 0 2.29 CISPEP 2 PHE H 217 PRO H 218 0 -2.94 SITE 1 AC1 10 TYR H 33 SER H 35 TYR H 47 TYR H 50 SITE 2 AC1 10 PHE H 98 GLU H 106 TYR H 159 HIS H 212 SITE 3 AC1 10 TRP H 214 PHE H 219 CRYST1 34.279 65.297 48.574 90.00 98.36 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029172 0.000000 0.004287 0.00000 SCALE2 0.000000 0.015315 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020808 0.00000